Interim report January-June 2016: Strong financial performance during the period
· Best quarterly- and half year result in the company’s history · Increased profitability in our Nordic clinics · Organic growth continues to be good · Situation analysis in United Arab Emirates completed Second quarter 2016 · Sales revenues increased to SEK 262.0 million (212.1) and organic growth amounted to 22 percent (6) · EBITDA amounted to SEK 31.8 million (17.8) · EBITDA margin amounted to 12.1 percent (8.4) · Result after tax (EAT) amounted to SEK 20.1 million (8.6) · Result per share amounted to SEK 0.26 (0.10) First half year 2016